StockData
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM) stock

MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30
$92.49+0.54 (+0.59%)

Close on Nov 18, 2026Market cap $6.01BP/E –Yield –

Mirum Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Mirum Pharmaceuticals's market cap was $6.13B on Nov 11, 2026, against $3.75B a year earlier. Over the last 5 years it ranged from $484.98M to $7.13B, with a median of $1.61B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.13B+51.1%
2025Dec 31, 2025$4.05B+104.4%
2024Dec 31, 2024$1.98B+44.2%
2023Dec 29, 2023$1.38B+91.6%
2022Dec 30, 2022$717.87M+48.0%
2021Dec 31, 2021$484.98M+10.2%
2020Dec 31, 2020$440.18M-20.5%
2019Dec 31, 2019$553.34M–

More Mirum Pharmaceuticals figures

See a number that looks wrong?